The representatives of Germany and USA will meet in mod-November and discuss the drug pricing policies.
President Trump has accustated that Germany pays too little for the new drugs and therefore the expenses of developing new drugs are left on the care of the USA. Germany, on the other hand, wishes to avoid the higher tariffs and German Chancellor Friedrich Merz assures that the drug pricing decisions are “a domestic matter”
The negotiations affect the whole Europe as France and Italy have faced similar kinds of pressure about drug pricing. French Trade Minister Nicolas Forissier comments that disagreements in the matter could crumble down European unity and cooperation
https://www.politico.eu/article/us-germany-talks-drug-pricing
